Cite
HARVARD Citation
Niu, S. et al. (2023). 18F‐DCFPyL positron emission tomography/magnetic resonance imaging‐guided ultrasound fusion biopsy is an identical pathway in prostate cancer diagnosis. Prostate. 83 (2), pp. 142-150. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Niu, S. et al. (2023). 18F‐DCFPyL positron emission tomography/magnetic resonance imaging‐guided ultrasound fusion biopsy is an identical pathway in prostate cancer diagnosis. Prostate. 83 (2), pp. 142-150. [Online].